# Novel Peptide Vaccination for Patients With Advanced Prostate Cancer

> **NCT01225471** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Iwate Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** CDCA1

## Key facts

- **NCT ID:** NCT01225471
- **Lead sponsor:** Iwate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2011-05
- **Final completion:** 2012-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225471, "Novel Peptide Vaccination for Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01225471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*